Médecine transfusionnelle
Description
Veille informationnelle portant sur la médecine transfusionnelle
Sujets couverts
Réactions transfusionnelles
Transformation du sang
Banque du sang
Maladies du sang
Utilisation de produits sanguins
Ressources
Sources
PubMed
Embase
Fréquence
Mensuelle
Bibliothécaire responsable
Romy Otayek
romy.otayek.chum@ssss.gouv.qc.ca
-
Should Transfusions of Donated G6PD-Deficient Donor Red Blood Cells Be Restricted to Improve Patient Safety? A Critical Review of the Current Literature
Le 9 juillet 2026
Publication date: July 2026 Source: Transfusion Medicine Reviews, Volume 40, Issue 3 Author(s): Matthew S Karafin, Richard O Francis
-
Patient blood management in general intensive care patients
Le 9 juillet 2026
Intensive Care Med. 2026 Jun;52(6):1290-1305. doi: 10.1007/s00134-026-08491-6. Epub 2026 Jun 8. ABSTRACT PURPOSE: Critically ill and high-risk perioperative patients requiring intensive care are often multimorbid and depend on rapid, highly specialized management. While most comorbidities are difficult to modify in the acute setting, anemia,…
-
Red Blood Cell Transfusion Characteristics and Morbidity or Mortality in Very-Low-Birth-Weight Infants
Le 9 juillet 2026
JAMA Netw Open. 2026 Jun 1;9(6):e2619301. doi: 10.1001/jamanetworkopen.2026.19301. ABSTRACT IMPORTANCE: Few studies have evaluated whether modifiable aspects of red blood cell (RBC) transfusions are associated with recipient outcomes in very-low-birth-weight (VLBW) infants. OBJECTIVE: To determine whether blood donor, RBC modifications and storage…
-
Optimizing platelet transfusion practices in hemato-oncology patients: A comprehensive analysis at a tertiary care oncology center
Le 9 juillet 2026
Asian J Transfus Sci. 2026 Jan-Jun;20(1):58-66. doi: 10.4103/ajts.ajts_29_24. Epub 2026 May 13. ABSTRACT BACKGROUND AND AIMS: Platelet transfusions play a crucial role in managing thrombocytopenia in hemato-oncology patients. This study aimed to analyze platelet transfusion practices and evaluate the correlation between clinical and laboratory…
-
Short‐term temperature excursion does not affect plasma and cryoprecipitate quality
Le 3 juin 2026
Abstract Background and Objectives Plasma and cryoprecipitate are stored below −25°C for optimal preservation of component quality. However, there may be situations in which components are exposed to higher temperatures and therefore discarded. This study aimed to determine the quality of plasma and cryoprecipitate following a short-term…
-
A novel reagent for the screening of Immunoglobulin A‐deficient blood donors
Le 3 juin 2026
Abstract Background and Objectives Immunoglobulin A (IgA) deficiency occurs in approximately 1 in 14,000 individuals in Japan. Approximately 32% harbour anti-IgA, most of which are naturally occurring and rarely cause anaphylaxis, although high-titre anti-IgA from alloimmunization can cause severe reactions. A stable supply of IgA-deficient plasma…
-
Implementation of a patient blood management programme for platelet therapy among haemato‐oncology patients—A quasi‐experimental study
Le 20 avril 2026
Abstract Background The paucity of data pertaining to the implementation of the patient blood management (PBM) programme for platelet transfusion for improved patient outcomes with minimal risks motivated this study. The study aimed to implement an effective PBM programme for platelet transfusion therapy among haemato-oncology patients evaluating…
-
Lower efficacy of transfusion of red blood cells from donors with sickle cell trait
Le 20 avril 2026
Hemasphere. 2026 Apr 14;10(4):e70360. doi: 10.1002/hem3.70360. eCollection 2026 Apr. ABSTRACT Sickle cell trait (SCT), the heterozygous state for the hemoglobin S (HbS) mutation, affects roughly 1 in 13 African American individuals and is common among blood donors recruited for antigen-matched transfusions in sickle cell disease (SCD). While…
-
Bridging the clinical equivalence gap: a nationwide survey on healthcare professionals' perceptions of whole blood-derived versus apheresis platelets in China
Le 20 avril 2026
Hematol Transfus Cell Ther. 2026 Apr 17;48(3):106453. doi: 10.1016/j.htct.2026.106453. Online ahead of print. ABSTRACT INTRODUCTION: Despite evidence supporting the clinical equivalence of whole blood-derived platelets (WBDP) and apheresis platelets (AP), AP remains the dominant choice for platelet transfusions in many countries. This study aimed…
-
Simulation-Based Training to Promote Whole Blood Administration Protocol Among Critical Care Transport of Trauma Patients
Le 20 avril 2026
Air Med J. 2026 Mar-Apr;45(2):121-125. doi: 10.1016/j.amj.2025.10.013. Epub 2025 Nov 25. ABSTRACT OBJECTIVE: Trauma patients often present to emergency departments with coagulopathies. Recognizing the unique challenges of caring for trauma patients and the urgent need for protocol-driven resuscitation is essential. METHODS: This project used a…
-
The Role of Artificial Intelligence in Transfusion Medicine
Le 20 avril 2026
Clin Lab Med. 2026 Mar;46(1):119-136. doi: 10.1016/j.cll.2025.10.007. Epub 2025 Dec 26. ABSTRACT Artificial intelligence (AI) is rapidly transforming the field of transfusion medicine by enhancing precision, efficiency, and safety across the transfusion continuum. This article provides a comprehensive overview of AI technologies and their…
-
Management of burn patients is linked to the development of anti-HLA antibodies in patients receiving cryopreserved skin allografts: A retrospective cohort
Le 20 avril 2026
Burns. 2026 May;52(4):107967. doi: 10.1016/j.burns.2026.107967. Epub 2026 Mar 11. ABSTRACT INTRODUCTION: Skin allografts are used to cover wounds in patients with severe burns. Owing to the allogeneic nature of the tissue, rejection often limits its effectiveness to a few weeks. The aim of this study was to analyse the factors influencing…
-
Early Haemoglobin response after single‐unit red blood cell transfusion predicts repeat transfusion in hospitalised adults: A prospective cohort study and clinical prediction model
Le 9 juillet 2026
Abstract Background Restrictive transfusion strategies and patient blood management programs increasingly recommend administration of single-unit red blood cell (RBC) transfusions followed by reassessment. However, clinicians often lack objective indicators to determine whether additional transfusion may subsequently be administered after the…
-
Postoperative transfusion-related acute lung injury in a young woman with corpus luteum cyst rupture: Case report and literature review
Le 9 juillet 2026
J Int Med Res. 2026 Jun;54(6):3000605261452582. doi: 10.1177/03000605261452582. Epub 2026 Jun 6. ABSTRACT This case study examines a 22-year-old unmarried woman who experienced shock resulting from rupture of a corpus luteum cyst. During the perioperative period, the patient received multiple transfusions of red blood cells and fresh frozen plasma…
-
Transfusion-Associated Graft-Versus-Host Disease Risk and Transfusion Requirements After Cladribine in Multiple Sclerosis: Time to Revise Irradiation Policy?
Le 9 juillet 2026
Eur J Neurol. 2026 Jul;33(7):e70698. doi: 10.1111/ene.70698. ABSTRACT BACKGROUND: Irradiation of cellular blood components prevents transfusion-associated graft-versus-host disease (TA-GVHD). UK and Spanish guidance recommend lifelong irradiation for all patients treated with purine analogues, including cladribine, irrespective of indication or…
-
Transfusion-transmitted cytomegalovirus infection in the era of universal leukoreduction and pathogen inactivation: a contemporary review
Le 3 juin 2026
Lab Med. 2026 Apr 3;57(3):lmag031. doi: 10.1093/labmed/lmag031. ABSTRACT INTRODUCTION: Transfusion-transmitted cytomegalovirus remains a clinically significant risk in immunocompromised individuals, neonates, and transplant recipients. Despite widespread universal leukoreduction and pathogen-reduction technologies, uncertainty persists regarding…
-
Transfusion reactions reported to the Québec haemovigilance system between 2005 and 2022: A comparison of paediatric and adult recipients
Le 20 avril 2026
Br J Haematol. 2026 Mar;208(3):1074-1083. doi: 10.1111/bjh.70371. Epub 2026 Feb 18. ABSTRACT Few studies have compared the prevalence of transfusion reactions (TRs) in paediatric and adult recipients, and none have been conducted in Canada. We carried out a retrospective cross-sectional study of TRs reported in a Canadian haemovigilance system (i…
-
Transfusion-induces donor-specific antibody boost leading to antibody-mediated rejection after heart transplantation: A case report
Le 20 avril 2026
Transpl Immunol. 2026 Apr;95:102365. doi: 10.1016/j.trim.2026.102365. Epub 2026 Feb 23. ABSTRACT Despite significant advances in immunosuppression strategies, antibody-mediated rejection (AMR) remains a leading cause of graft dysfunction and loss after heart transplantation. Donor-specific anti-HLA antibodies (DSA), either preformed or de novo,…
-
The burden and correlates of bloodborne pathogens in a Zambian Blood Donor Cohort
Le 20 avril 2026
PLoS One. 2026 Apr 6;21(4):e0346680. doi: 10.1371/journal.pone.0346680. eCollection 2026. ABSTRACT INTRODUCTION: Transfusion is a critical life-saving intervention, but the safety of the blood supply remains a major public health concern, particularly in sub-Saharan Africa, due to the risk of transfusion-transmitted infections (TTIs). This study…
-
Mitochondrial DNA as a Damage-Associated Molecular Pattern in Stored Blood: Mechanisms of Transfusion-Induced Sterile Inflammation
Le 20 avril 2026
New Microbiol. 2026 Apr;49(1):11-17. ABSTRACT Transfusion of stored red blood cells (RBCs) is a life-saving intervention in trauma, surgery, and critical care. However, storage-induced alterations, collectively termed "storage lesions," lead to the accumulation of bioactive mediators, including mitochondrial DNA (mtDNA), which functions as a…
-
Adverse Reactions to Blood Transfusion in Pediatric Cardiac Surgery: A Retrospective Cohort Study at a Single Center
Le 20 avril 2026
Ann Card Anaesth. 2026 Apr 1;29(2):204-211. doi: 10.4103/aca.aca_208_25. Epub 2026 Apr 15. ABSTRACT OBJECTIVES: Blood transfusion is an integral part of pediatric cardiac surgery. Our study intends to analyze the incidence of transfusion reactions in pediatric cardiac surgery patients. Secondary objectives were to identify the common type of…
-
Impact of Perfusion With Methylene Blue on Perioperative Bleeding in Simultaneous Pancreas and Kidney Transplantation: A Randomized Control Trial
Le 9 juillet 2026
Transplant Direct. 2026 Jul 2;12(8):e1972. doi: 10.1097/TXD.0000000000001972. eCollection 2026 Aug. ABSTRACT BACKGROUND: Simultaneous pancreas-kidney transplantation (SPK) is the optimal treatment for selected patients with type I diabetes mellitus (T1DM) and end-stage kidney disease, but intraoperative bleeding remains a major cause of morbidity…
-
Unlocking thalidomide response as a hemoglobin F augmentation agent in transfusion-dependent beta-thalassemia: the genetic impact of BCL11A, HBS1L-MYB, and XmnI polymorphism
Le 9 juillet 2026
Diagn Pathol. 2026 Jul 7. doi: 10.1186/s13000-026-01797-5. Online ahead of print. ABSTRACT BACKGROUND: Thalidomide has been found to augment fetal hemoglobin (HbF) synthesis, thereby decreasing transfusion requirements in patients with β-thalassemia. Elevated fetal hemoglobin, influenced by genetic polymorphisms, can significantly modify the…
-
Optimization and Performance Evaluation of Melt-Blown Fiber Membranes for Leukocyte Separation from Whole Blood
Le 3 juin 2026
ACS Omega. 2026 May 13;11(20):29683-29690. doi: 10.1021/acsomega.5c13313. eCollection 2026 May 26. ABSTRACT Leukocytes need to be eliminated from blood components in order to lower the risk of adverse transfusion responses and guarantee patient safety during transfusion. Nowadays, nonwoven fabric filters are typically used to remove leukocytes…
-
An in-house nucleic acid test for detection of Anaplasma phagocytophilum in whole blood donor samples
Le 20 avril 2026
Transfusion. 2026 Apr 13. doi: 10.1111/trf.70194. Online ahead of print. ABSTRACT BACKGROUND: Anaplasma phagocytophilum is a tick-borne pathogen that causes anaplasmosis. Increased incidences of this disease in Canada and cases of transfusion-transmitted anaplasmosis in the United States have been reported. Currently, there are no Health Canada…
-
Clot contraction of whole blood diminishes during storage and can be restored by adding platelets
Le 9 juillet 2026
Abstract Background The contraction of blood clots is a dramatic platelet-dependent process that minimizes the impact of thrombosis and supports the closure of lacerations. Whole blood (WB) stored up to 35 days is increasingly used to treat hemorrhagic shock, but the clot contractibility of this stored blood is unknown. We hypothesized that clot…
-
Monitoring and feedback using data in transfusion medicine: A study of practices from the BEST Collaborative
Le 9 juillet 2026
Transfusion. 2026 Jun 22. doi: 10.1111/trf.70316. Online ahead of print. ABSTRACT BACKGROUND: It is imperative that health systems monitor transfusion practice quality and implement improvements when evidence-based practice gaps are identified. Despite the importance of data-driven quality activities, little is known about approaches employed by…
-
Organizational monitoring of patient blood management implementation: Results of an Italian national survey
Le 3 juin 2026
Vox Sang. 2026 May 15. doi: 10.1111/vox.70267. Online ahead of print. ABSTRACT BACKGROUND AND OBJECTIVES: Patient blood management (PBM) as a standard-of-care approach, sustained by substantial scientific literature, is now widely supported by national and international recommendations and guidelines. Scientific evidence shows that PBM is a…
-
Reducing blood product wastage: Insights from a retrospective study in a tertiary health facility
Le 20 avril 2026
PLoS One. 2026 Mar 25;21(3):e0344521. doi: 10.1371/journal.pone.0344521. eCollection 2026. ABSTRACT INTRODUCTION: Due to the absence of prior institutional assessments and limited local studies lacking key performance indicators, this study examines the operational efficiency of the blood bank at King Fahad Medical City (KFMC) in Riyadh, Saudi…
-
The efficacy of interactive communication interventions for motivating blood donation: A systematic review
Le 20 avril 2026
Abstract Background and Objectives The global blood product shortage is a persistent problem that urgently needs addressing. Research has investigated the effects of incentives, different interventions and different modes of communication on promoting blood donation; yet, there has been no systematic review comparing interactive communication…
-
Low titer group O whole blood inventory conservation: The effect of implementing group A whole blood at a simulated civilian trauma center
Le 20 avril 2026
Abstract Background Substituting group A whole blood (GAWB) might relieve some of the burden on the low titer group O whole blood (LTOWB) inventory. This simulation examined the effect of implementing GAWB at a large trauma hospital. Study Design and Methods A civilian trauma center with LTOWB and GAWB par levels set to 22 and 10 units,…
-
Effect of long-term frozen storage on antibodies in blood samples: immunoglobulin, tetanus toxin antibody, and ABO antibody
Le 20 avril 2026
Immunohematology. 2026 Apr 10;42(1):6-13. doi: 10.2478/immunohematology-2026-003. Print 2026 Mar 1. ABSTRACT The Japanese Red Cross Blood Services archives donor blood samples from all donations for look-back surveys. These samples, approximately 5 million per year, are stored frozen at -30°C for 11 years and are subsequently discarded. Because…
-
Latent iron deficiency as a silent driver of donor attrition in high-frequency plateletpheresis donors: a longitudinal cohort study
Le 20 avril 2026
Ann Hematol. 2026 Apr 16;105(5):248. doi: 10.1007/s00277-026-06992-4. ABSTRACT High-frequency plateletpheresis is crucial for meeting transfusion demands but poses a significant risk of cumulative iron depletion in donors. Current screening protocols relying solely on hemoglobin (Hb) fail to detect latent iron deficiency (LID), a condition where…
-
Alternative Conditioning Regimens for Hemoglobinopathy Gene Therapy: Balancing Efficacy, Toxicity, and the Next Frontier
Le 9 juillet 2026
Blood Adv. 2026 Jul 8:bloodadvances.2026019856. doi: 10.1182/bloodadvances.2026019856. Online ahead of print. ABSTRACT Gene therapy for sickle cell disease and transfusion-dependent thalassemia is now widely available, yet its broader application is constrained by the need for effective and tolerable conditioning. This review examines the central…
-
Splenectomy Impact and Outcome Among Patients With Sickle Cell Disease: A Cross-Sectional Study
Le 9 juillet 2026
Health Sci Rep. 2026 Jul 7;9(7):e72778. doi: 10.1002/hsr2.72778. eCollection 2026 Jul. ABSTRACT BACKGROUND: It is common to perform a splenectomy for patients with sickle cell disease (SCD); however, our understanding of its impact on long-term clinical outcomes remains incomplete. OBJECTIVES: To evaluate the clinical outcomes of splenectomy in…
-
Mortality and Functional Outcomes of Liberal versus Restrictive Blood Transfusion in Elderly Patients after Hip Surgery: A Randomised Control Trial
Le 3 juin 2026
Hip Pelvis. 2026 Jun 1;38(2):187-195. doi: 10.5371/hp.2026.38.2.187. ABSTRACT PURPOSE: There is ongoing debate on the haemoglobin level at which red cell transfusion should be administered following surgery. This study aimed to evaluate the benefits of a restrictive blood transfusion strategy and assess potential adverse effects of anaemia in the…
-
Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis
Le 3 juin 2026
Blood. 2026 Jun 2:blood.2025032290. doi: 10.1182/blood.2025032290. Online ahead of print. ABSTRACT Non-myeloablative-related haploidentical allogeneic stem cell transplantation (NMAC-HID allo-HSCT) emerged as an additional treatment for achieving durable remission in SCD, a prevalent blood disorder characterized by painful vaso-occlusive crises…
-
Stealth red blood cells with broad-spectrum antigenic shielding for transfusion therapy in antibody-mediated hemolytic anemia
Le 3 juin 2026
Biomaterials. 2026 May 28;335:124345. doi: 10.1016/j.biomaterials.2026.124345. Online ahead of print. ABSTRACT Red blood cell (RBC) transfusion is a cornerstone of life-sustaining therapy, yet it is profoundly challenged in autoimmune hemolytic anemia (AIHA). In this disorder, a diverse array of autoantibodies targets both the autologous and…
-
Glycemic control and blood product quality of Canadian blood donors with diabetes
Le 20 avril 2026
Abstract Background Many blood centers now accept donors with diabetes, provided their condition is “well-controlled”. However, glycemic control is not routinely assessed at donation, and the impact of donor diabetes on blood product quality remains unclear. Study Design and Methods To screen glycemic control, glycated hemoglobin A1c (HbA1c) was…
-
Evaluating Hemoglobin Thresholds for Blood Transfusions in Oncology Patients Admitted to the Intensive Care Unit
Le 20 avril 2026
J Hematol. 2026 Apr 6;15(2):80-89. doi: 10.14740/jh2178. eCollection 2026 Apr. ABSTRACT BACKGROUND: In the intensive care unit (ICU), up to 90% of patients develop anemia during their stay. However, evidence regarding transfusion practices in oncology patients requiring ICU-level care is limited. This study aimed to compare mortality, survival…
-
Risk factors for preoperative anemia in orthognathic surgery patients undergoing autologous blood donation: A cross-sectional study
Le 20 avril 2026
Medicine (Baltimore). 2026 Apr 10;105(15):e48140. doi: 10.1097/MD.0000000000048140. ABSTRACT In Japan, preoperative autologous blood donation (ABD) is widely performed in orthognathic surgery to avoid allogeneic transfusion. Although previous studies have examined postoperative hemoglobin (Hb) fluctuations and the safety of autologous blood…
-
Association of an integrated prehospital-to-in-hospital transfusion workflow with early outcomes in severe trauma requiring emergency transfusion: A single-center observational before-and-after study
Le 9 juillet 2026
J Int Med Res. 2026 Jul;54(7):3000605261463827. doi: 10.1177/03000605261463827. Epub 2026 Jul 6. ABSTRACT ObjectiveTo evaluate the association between a prehospital-to-in-hospital integrated transfusion workflow and transfusion timeliness, coagulation-related indices, and short-term clinical outcomes in patients with severe trauma requiring…
-
Whole-Blood Transfusion From Empiricism to Evidence: A Narrative Review
Le 9 juillet 2026
JAMA Surg. 2026 Jul 8. doi: 10.1001/jamasurg.2026.2574. Online ahead of print. ABSTRACT IMPORTANCE: Hemorrhage remains the leading preventable cause of trauma death, and many fatalities occur before definitive hemorrhage control. Whole blood has reemerged as a promising strategy for early hemostatic resuscitation. However, its modern role remains…
-
Longitudinal Changes in Transfusion Practice in Myelodysplastic Syndromes: A Population Data-Linkage Study
Le 3 juin 2026
Eur J Haematol. 2026 May 31. doi: 10.1111/ejh.70233. Online ahead of print. ABSTRACT BACKGROUND: Real-world data on transfusion needs of patients with myelodysplastic syndromes (MDS), and the impacts of disease-modifying therapies (DMTs) are sparse. In 2011, 5-azacitidine became the first funded DMT for MDS and chronic myelomonocytic leukaemia …
-
Beta-Thalassemia in Spain: Results From the National Thalassemia Registry and Molecular Analysis of Patients With Transfusion-Dependent Thalassemia
Le 3 juin 2026
J Clin Lab Anal. 2026 Jun 2:e70272. doi: 10.1002/jcla.70272. Online ahead of print. ABSTRACT BACKGROUND: Beta-thalassemia is a genetically heterogeneous hemoglobinopathy with marked clinical variability. In Spain, comprehensive nationwide data on transfusion-dependent beta-thalassemia (TDT) remain limited, particularly regarding molecular…
-
An in‐house nucleic acid test for detection of Anaplasma phagocytophilum in whole blood donor samples
Le 20 avril 2026
Abstract Background Anaplasma phagocytophilum is a tick-borne pathogen that causes anaplasmosis. Increased incidences of this disease in Canada and cases of transfusion-transmitted anaplasmosis in the United States have been reported. Currently, there are no Health Canada licensed methodologies available for detection of A. phagocytophilum nucleic…